UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of clinical oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 2, pp. 240 - 246
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Prognosis | Humans | Middle Aged | Immunophenotyping | Male | Treatment Outcome | Young Adult | Disease-Free Survival | Immunoblastic Lymphadenopathy - therapy | Lymphoma, T-Cell, Peripheral - pathology | Aged, 80 and over | Adult | Female | Immunoblastic Lymphadenopathy - pathology | Aged | Lymphoma, T-Cell, Peripheral - therapy | Immunoblastic Lymphadenopathy - immunology | Lymphoma, T-Cell, Peripheral - immunology | Index Medicus | Hema25 | ORIGINAL REPORTS | Hema19 | Hema21
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 09/2009, Volume 27, Issue 27, pp. 4555 - 4562
Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Predictive Value of Tests | Lymphoma, Follicular - therapy | Prognosis | Risk Assessment | Humans | Middle Aged | Lymphoma, Follicular - diagnosis | Disease Progression | Young Adult | Disease-Free Survival | Aged, 80 and over | Adult | Aged | Index Medicus
Journal Article
Haematologica (Roma), ISSN 0390-6078, 03/2012, Volume 97, Issue 3, pp. 416 - 422
Dexamethasone | Salvage treatment | Lenalidomide | Relapsed/refractory disease | Mantle cell lymphoma | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Biomarkers - metabolism | Tumor Microenvironment - drug effects | Recurrence | Dexamethasone - administration & dosage | Humans | Middle Aged | Salvage Therapy | Lymphoma, Mantle-Cell - drug therapy | Male | Treatment Outcome | Thalidomide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Lymphoma, Mantle-Cell - mortality | Thalidomide - analogs & derivatives | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Female | Aged | Neovascularization, Pathologic - metabolism | Index Medicus | dexamethasone | refractory disease | Original and Brief Reports | relapsed | mantle cell lymphoma | lenalidomide | salvage treatment
Journal Article
Blood, ISSN 0006-4971, 10/2017, Volume 130, Issue 16, pp. 1780 - 1781
Journal Article
Blood, ISSN 0006-4971, 10/2015, Volume 126, Issue 15, pp. 1733 - 1734
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 06/2006, Volume 24, Issue 16, pp. 2472 - 2479
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Immunohistochemistry | Predictive Value of Tests | Prognosis | Follow-Up Studies | Tissue Array Analysis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Antigens, CD - analysis | In Situ Hybridization | Lymphoma, T-Cell, Peripheral - chemistry | Multicenter Studies as Topic | Ki-1 Antigen - analysis | Aged, 80 and over | Adult | Female | CD5 Antigens - analysis | Retrospective Studies | Antigens, CD20 - analysis | CD2 Antigens - analysis | Lewis X Antigen - analysis | Biomarkers, Tumor - analysis | Neprilysin - analysis | Proportional Hazards Models | Clinical Trials as Topic | Antigens, CD7 - analysis | CD8 Antigens - analysis | CD3 Complex - analysis | Phenotype | Ki-67 Antigen - analysis | CD4 Antigens - analysis | Lymphoma, T-Cell, Peripheral - pathology | Survival Analysis | Aged | Biomarkers, Tumor - immunology | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2015, Volume 373, Issue 18, pp. 1733 - 1747
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Arthralgia - chemically induced | Indoles - administration & dosage | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Aged, 80 and over | Adult | Female | Leukemia, Hairy Cell - pathology | Administration, Oral | Leukemia, Hairy Cell - genetics | Proto-Oncogene Proteins - genetics | Biomarkers - blood | Remission Induction | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Disease-Free Survival | Drug Resistance, Neoplasm - genetics | Indoles - adverse effects | Proto-Oncogene Proteins B-raf - genetics | Bone Marrow - pathology | Leukemia, Hairy Cell - drug therapy | Sulfonamides - adverse effects | Aged | Mutation | Sulfonamides - administration & dosage | Vemurafenib | Care and treatment | Health aspects | Leukemia, Hairy cell | Inhibitor drugs | Leukemia | Arthralgia | Genes | Clinical trials | Extracellular signal-regulated kinase | Bone marrow | Arthritis | Kinases | Patients | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Human pathology, ISSN 0046-8177, 08/2019, Volume 90, pp. 60 - 69
Polysomy | Breast implant | Copy gain | Anaplastic lymphoma | PDL1 | Life Sciences & Biomedicine | Pathology | Science & Technology | Immunohistochemistry | Phosphorylation | Breast Implants - adverse effects | Humans | Middle Aged | Breast Neoplasms - etiology | Lymphoma, Large-Cell, Anaplastic - etiology | B7-H1 Antigen - genetics | DNA Copy Number Variations | B7-H1 Antigen - metabolism | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Adult | Female | Aged | Biomarkers, Tumor - genetics | Lymphoma, Large-Cell, Anaplastic - pathology | STAT3 Transcription Factor - metabolism | Lymphoma, Large-Cell, Anaplastic - genetics | Implants, Artificial | Prosthesis | Cell death | Analysis | Aluminum compounds | Cytogenetics | Lymphomas | Genetic transcription | T cells | Antigens | Gene amplification | Lymphatic system | Transplants & implants | Cloning | Breast implants | Breast cancer | Mutation | Kinases | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2009, Volume 27, Issue 11, pp. 1781 - 1787
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Recurrence | Lymphoma - diagnosis | Prospective Studies | Follow-Up Studies | Lymphoma - diagnostic imaging | Humans | Fluorodeoxyglucose F18 | Lymphoma - pathology | Positron-Emission Tomography | Radiopharmaceuticals | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 11/2012, Volume 30, Issue 31, pp. 3848 - 3853
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Lymphoma, Follicular - drug therapy | Lymphoma, Follicular - pathology | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Lymphoma, Follicular - diagnosis | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Rituximab | Male | Treatment Outcome | Tumor Burden | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Adult | Female | Watchful Waiting | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Cohort Studies | Index Medicus
Journal Article
Cancers, ISSN 2072-6694, 05/2019, Volume 11, Issue 5, p. 595
Journal Article
Best practice & research. Clinical haematology, ISSN 1521-6926, 2016, Volume 30, Issue 1-2, pp. 50 - 55
Hematology, Oncology and Palliative Medicine | Marginal zone | Malignant | Lymph node | Lymphoma | Life Sciences & Biomedicine | Hematology | Science & Technology | Lymphoma, B-Cell, Marginal Zone - therapy | Lymphoma, B-Cell, Marginal Zone - pathology | Lymphoma, B-Cell, Marginal Zone - classification | Humans | Lymphoma, B-Cell, Marginal Zone - genetics | Lymphomas | Index Medicus
Journal Article
BMC cancer, ISSN 1471-2407, 12/2012, Volume 12, Issue 1, pp. 586 - 586
Glycolysis | GLUT1 | Hodgkin lymphoma | Warburg effect | Life Sciences & Biomedicine | Oncology | Science & Technology | Hodgkin Disease - diagnostic imaging | Prognosis | Hodgkin Disease - metabolism | Biomarkers, Tumor - analysis | Hodgkin Disease - pathology | Humans | Kaplan-Meier Estimate | Male | Positron-Emission Tomography | Germinal Center - pathology | Disease-Free Survival | Glucose Transporter Type 1 - analysis | Germinal Center - metabolism | Glucose Transporter Type 1 - biosynthesis | Adult | Female | Germinal Center - diagnostic imaging | Proteins | Glucose metabolism | Carrier proteins | B cells | Non-Hodgkin's lymphomas | Glucose | Dextrose | Hodgkin's disease | Index Medicus
Journal Article